These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4035697)

  • 21. Role of carboxylesterase in protection against soman toxicity.
    Purshottam T; Srivastava R
    Pharmacology; 1989; 38(5):319-26. PubMed ID: 2762374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinesterase and carboxylesterase activities in soman poisoned rats treated with bispyridinium mono-oximes HI-6 and HS-6.
    Sterri SH; Lyngaas S; Fonnum F
    Biochem Pharmacol; 1983 May; 32(10):1646-9. PubMed ID: 6860351
    [No Abstract]   [Full Text] [Related]  

  • 23. Stereoselectivity of enzymes involved in toxicity and detoxification of soman.
    Nordgren I; Lundgren G; Puu G; Holmstedt B
    Arch Toxicol; 1984 Mar; 55(1):70-5. PubMed ID: 6732508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers of low-level exposure to soman vapor: comparison of fluoride regeneration to acetylcholinesterase inhibition.
    Dabisch PA; Davis EA; Renner JA; Jakubowski EM; Mioduszewski RJ; Thomson SA
    Inhal Toxicol; 2008 Jan; 20(2):149-56. PubMed ID: 18236229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.
    Yang ZP; Dettbarn WD
    Biochem Pharmacol; 1998 May; 55(9):1419-26. PubMed ID: 10076534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of acetylcholinesterase-inhibition on the tonus of guinea-pig bronchial smooth muscle.
    Aas P; Walday P; Tansø R; Fonnum F
    Biochem Pharmacol; 1988 Nov; 37(21):4211-6. PubMed ID: 3190758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and sub-acute inhalation of an organophosphate induce alteration of cholinergic muscarinic receptors.
    Aas P; Veiteberg TA; Fonnum F
    Biochem Pharmacol; 1987 Apr; 36(8):1261-6. PubMed ID: 3593413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacodynamic model for soman in the rat.
    Maxwell DM; Vlahacos CP; Lenz DE
    Toxicol Lett; 1988 Oct; 43(1-3):175-88. PubMed ID: 3176063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution and elimination of the stereoisomers of soman and their effect on brain acetylcholine.
    Nordgren I; Lundgren G; Puu G; Karlén B; Holmstedt B
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S252-9. PubMed ID: 3005100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of blood cholinesterase activities following administration of soman by different routes in guinea-pig.
    Sterri SH; Kloster O; Valdal G
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):326-31. PubMed ID: 7113708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity of soman after repetitive injection of sublethal doses in rat.
    Sterri SH; Lyngaas S; Fonnum F
    Acta Pharmacol Toxicol (Copenh); 1980 Jan; 46(1):1-7. PubMed ID: 7361558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathy target esterase in hens after sarin and soman.
    Crowell JA; Parker RM; Bucci TJ; Dacre JC
    J Biochem Toxicol; 1989; 4(1):15-20. PubMed ID: 2769693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and behavioral effects of soman vapors in low concentrations.
    Bajgar J; Sevelová L; Krejcová G; Fusek J; Vachek J; Kassa J; Herink J; de Jong LP; Benschop HP
    Inhal Toxicol; 2004 Jul; 16(8):497-507. PubMed ID: 15204741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium pentobarbital alteration of the toxicity and distribution of soman (pinacolyl methylphosphonofluoridate) in mice.
    Clement JG
    Biochem Pharmacol; 1984 Feb; 33(4):683-5. PubMed ID: 6704186
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice.
    Shapira S; Kadar T; Cohen G; Chapman S; Raveh L
    Arch Toxicol; 1990; 64(8):663-8. PubMed ID: 2090035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the cholinergic activity of bronchial muscle during inhalation of soman.
    Fonnum F; Aas P; Sterri S; Helle KB
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S52-7. PubMed ID: 6724215
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of inhibitors and other factors on cholinesterases.
    Bajgar J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1991; 34(1):5-77. PubMed ID: 1759111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. iso-OMPA-induced potentiation of soman toxicity in rat.
    Gupta RC; Dettbarn WD
    Arch Toxicol; 1987; 61(1):58-62. PubMed ID: 3439875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of soman (1,2,2-trimethylpropyl methylphosphonofluoridate) via fluoride-induced reactivation of soman-inhibited aliesterase in rat plasma.
    de Jong LP; van Dijk C
    Biochem Pharmacol; 1984 Feb; 33(4):663-9. PubMed ID: 6704183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.